Results 1 to 10 of about 8,911,089 (208)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment.

PLoS ONE, 2023
BackgroundHyperuricemia is common during tuberculosis (TB) treatment, especially in association with pyrazinamide (PZA). This study investigated the relationship between major adverse cardiovascular events (MACEs) and hyperuricemia during TB treatment ...
Hong-Joon Shin, Joon-Young Yoon, Young-Ok Na, Jae-Kyeong Lee, Bo Gun Kho, Tae-Ok Kim, Yu-Il Kim, Sung-Chul Lim, Sae-Hee Jeong, Yong-Soo Kwon   +9 more
doaj   +4 more sources

Prediabetes as a risk factor for major adverse cardiovascular events [PDF]

Annals of Medicine, 2021
Introduction Type II diabetes mellitus (DM) is a proinflammatory process and a known risk factor for major adverse cardiac events (MACE). The same inflammatory markers may be present in prediabetes (pDM); however, the relationship between pDM by HbA1c ...
Ramy Mando, Muhammad Waheed, Adrian Michel, Patrick Karabon, Alexandra Halalau   +4 more
doaj   +3 more sources

Age and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: a post hoc analysis of the randomized PATH-PCI trial

Platelets, 2023
It is particularly important to establish more effective and safer antiplatelet treatment strategies according to age. The present subanalysis of the PATH-PCI trial was to determine the safety and efficacy of any dual-antiplatelet therapy (DAPT) strategy
Ying Pan, Ting-Ting Wu, Xian-Geng Hou, Yi Yang, Chang-Jiang Deng, Shun Wang, Ying-Ying Zheng, Xiang Xie   +7 more
doaj   +1 more source

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Peripheral arterial disease (PAD) is a severe complication in patients with type 2 diabetes. Glycemic variability (GV) is associated with increased risks of developing microvascular and macrovascular diseases. However, few studies have focused
Jung‐Chi Hsu, Yen‐Yun Yang, Shu‐Lin Chuang, Kuan‐Chih Huang, Jen‐Kuang Lee, Lian‐Yu Lin   +5 more
doaj   +1 more source

Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischemic risk compared with 75–100 mg aspirin daily in coronary artery disease patients: insights from the TIFU (Ticagrelor in Fuwai Hospital) study

Platelets, 2020
Patients treated with ticagrelor and aspirin usually suffer from bleeding events, especially mild bleeding which is one of the main factors reducing patients’ adherence to ticagrelor.
Jiannan Li, Zhaoxue Sheng, Yu Tan, Chen Liu, Peng Zhou, Jinying Zhou, Runzhen Chen, Yi Chen, Li Song, Hanjun Zhao, Hongbing Yan   +10 more
doaj   +1 more source

Different Long-Term Outcomes According to Thrombus Histology in Patients With Acute Ischemic Stroke [PDF]

Journal of Stroke
Background and Purpose The relationship between thrombus histology and long-term stroke patient outcomes remains unexplored. We aimed to determine whether the histological characteristics of thrombi are associated with long-term outcomes in stroke ...
Hyungwoo Lee, JoonNyung Heo, Jae Wook Jung, Hyo Suk Nam, Ji Hoe Heo, Minyoul Baik, Joonsang Yoo, Jinkwon Kim, Tae-Jin Song, Gyu Sik Kim, Kwon-Duk Seo, Tae Dong Ok, Jin Kyo Choi, Il Kwon, Young Dae Kim, on Behalf of the SMART-CLOT Study Group   +15 more
doaj   +1 more source

Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis

Diabetology & Metabolic Syndrome, 2021
Background Hypertriglyceridemia (HTG) is considered an independent risk factor for major adverse cardiovascular events (MACE). Methods This study analyzed the effects of various agents on MACE risk reduction in HTG (serum triglyceride ≥ 150 mg/dl ...
Yan-yan Qi, Li Yan, Zhong-min Wang, Xi Wang, Hua Meng, Wen-bo Li, Dong-chang Chen, Meng Li, Jun Liu, Song-tao An   +9 more
doaj   +1 more source

ADS Score as a Novel Predictor of Outcomes in Patients Who Underwent Percutaneous Coronary Intervention

Frontiers in Cardiovascular Medicine, 2021
Objectives: A novel AFR– albumin-derived neutrophil to lymphocyte ratio (dNLR) score (ADS) were reported to associate with clinical outcome in various malignancies, However, the relation between the ADS score and outcomes in coronary artery disease (CAD)
Wen-Jing Zhang, Wen-Jing Zhang, Gang-Qiong Liu, Gang-Qiong Liu, Jia-Hong Shangguan, Jia-Hong Shangguan, Xiao-Dan Zhu, Xiao-Dan Zhu, Wei Wang, Qian-Qian Guo, Qian-Qian Guo, Jian-Chao Zhang, Jian-Chao Zhang, Kai Wang, Kai Wang, Zhi-Yu Liu, Zhi-Yu Liu, Feng-Hua Song, Feng-Hua Song, Lei Fan, Lei Fan, Ling Li, Ying-Ying Zheng, Ying-Ying Zheng, Jin-Ying Zhang, Jin-Ying Zhang   +25 more
doaj   +1 more source

Target-specific cardiotoxicity of tyrosine kinase inhibitors: a Systematic Review and meta-analysis

Frontiers in Pharmacology
ObjectiveTo assess the association between different tyrosine kinase inhibitors (TKIs) and the risk of major adverse cardiovascular events (MACE).Data sourcesPubMed, the Cochrane Library, Embase, WanFang Data, and CNKI were searched for randomized ...
Zhe Wang, Zhe Wang, Zhiling Cheng, Zhiling Cheng, Yifan Zheng, Yifan Zheng, Yang Liu, Zhihan Zhang, Yuan Gao, Congxin Li, Congxin Li   +10 more
doaj   +1 more source

Predicting Major Adverse Cardiovascular Events Following Carotid Endarterectomy Using Machine Learning

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Carotid endarterectomy (CEA) is a major vascular operation for stroke prevention that carries significant perioperative risks; however, outcome prediction tools remain limited.
Ben Li, Raj Verma, Derek Beaton, Hani Tamim, Mohamad A. Hussain, Jamal J. Hoballah, Douglas S. Lee, Duminda N. Wijeysundera, Charles de Mestral, Muhammad Mamdani, Mohammed Al‐Omran   +10 more
doaj   +1 more source